Source Bioscience LifeSciences Aquires imaGenes GmbH
News Dec 07, 2010
imaGenes is a premier provider of genome research services and products in Europe, managing a comprehensive clone collection and offering an exciting range of services including microarray, protein arrays and DNA sequencing. imaGenes’ high end bioinformatic expertise complement the Group’s investment in leading edge next generation sequencing.
Dr Nick Ash, CEO of Source BioScience, said: “The acquisition of imaGenes provides a platform for increased penetration of the European life science research and healthcare markets, acting as a catalyst for accelerated growth. The imaGenes team will bring significant depth of experience and knowledge to the Group and we will be able to leverage their existing links with academic centres and research institutions across Europe.”
With cybersecurity one of the nation's top security concerns and billions of people affected by breaches last year, government and businesses are spending more time and money defending against it. Researchers at the Army's corporate research laboratory, in collaboration with Towson University, may have identified a new way to improve network security.